hoodb.com

《貧血》不同調! 雖因血栓風險遭美國FDA拒絕, FibroGen與Astellas口服貧血藥物Evrenzo獲英國藥價管理當局納入保險給付- 生技投資第一站

|

You are leaving and open the following URL" of about "hif" news

news.google.com/rss/articles/CBMia0FVX3lxTE9MakJIMmZCN3pLamZTcnc1RWFRbkJvV3QxdnBlT1liRWZiaEh3UDJSQTJQSWpiMlZhekFpanB3MGRLWnZYb2F2SXFCeXZTbnJpTk9qOGpHZC1SOVNvdVFjQ1BVa2gxdmFnREc0?oc=5


Continue Opne >

hif: 《貧血》不同調! 雖因血栓風險遭美國FDA拒絕, FibroGen與Astellas口服貧血藥物Evrenzo獲英國藥價管理當局納入保險給付- 生技投資第一站


More hif news:



Warning: filemtime(): stat failed for aCache/aaa/gnews/CA/hif.xml in /var/www/hoodb/function.php on line 339
1734941331-
Warning: file_put_contents(aCache/aaa/gnews/CA//hif.xml): Failed to open stream: No space left on device in /var/www/hoodb/function.php on line 348

About hif

from
1734941335-1734456929

Warning: filemtime(): stat failed for aCache/search/ca/hif in /var/www/hoodb/function.php on line 339
1734941335-

hif, 《貧血》不同調! 雖因血栓風險遭美國FDA拒絕, FibroGen與Astellas口服貧血藥物Evrenzo獲英國藥價管理當局納入保險給付- 生技投資第一站 2022 hif

《貧血》不同調! 雖因血栓風險遭美國FDA拒絕, FibroGen與Astellas口服貧血藥物Evrenzo獲英國藥價管理當局納入保險給付- 生技投資第一站

Choose Your Country or Region


Back to Top



《貧血》不同調! 雖因血栓風險遭美國FDA拒絕, FibroGen與Astellas口服貧血藥物Evrenzo獲英國藥價管理當局納入保險給付- 生技投資第一站

Copyright © 2020-2021 hoodb.com. All Rights Reserved.